L 687795
Latest Information Update: 07 Jun 2001
At a glance
- Originator Merck & Co
- Class Macrolides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 07 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)